Auntea Jenny Drops 23% in a Month as Borrow Costs Quadruple
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Auntea Jenny has shed nearly a quarter of its value over the past month while the cost of borrowing its shares has risen fourfold, a pairing that sets up an awkward question ahead of its October 30 earnings print.
The price story is stark. The stock closed at HK$59.00 on October 16, down 9% on the week and 23% over the past month. The one-day drop alone was 4.8%. That kind of sustained selling in a stock with negligible short positioning points to something more fundamental than short-seller pressure driving the decline.
The borrow market tells an interesting side story. Cost to borrow has climbed to 19.4%, more than four times where it stood a month ago and up 134% on the week alone. That is a high level for a Hong Kong-listed name, and the direction of travel has been consistently upward since June, when the rate was below 6%. Yet the lending pool itself remains wide open: availability is essentially uncapped, with 21 million shares available and no meaningful short interest on record. The rising cost to borrow without any corresponding buildup of short positions is an unusual combination. It may reflect a small, illiquid borrow market where even modest demand moves the rate sharply, rather than a wave of investors taking directional short bets. The days-to-cover factor score ranks in the 99th percentile, flagging just how thinly traded the float is relative to any borrow activity.
The analyst picture offers little fresh guidance. The three analysts on record lean bullish, with a consensus buy and a mean price target of HK$88.35, implying roughly 50% upside from the current price. That target, however, dates to April 2026, more than six months ago, and should be treated as stale. No recent changes have been filed. With the stock down 23% since that consensus was set, the gap between analyst expectations and market reality has widened considerably without any fresh Street commentary to bridge it.
Ownership is tightly held and highly concentrated. Three Shanghai-based entities, Puhai Enterprise Management, Senrui Enterprise Management Partnership, and Yuchao Enterprise Management Partnership, together control roughly 78% of the shares. Suzhou Weite Lixin adds another 8%. That leaves a thin free float, which explains both the elevated borrow rate mechanics and why price moves can be amplified in either direction. Institutional ownership outside the founding-related entities is minimal: SEI Investments and State Street both reported new positions at end of September, each holding fewer than 36,000 shares.
Insider activity from July was classified as "Other" transactions with no price attached, offering no read on conviction at that time.
The earnings history shows mixed reactions. The August 2026 interim result was almost flat on the day. The July 31 trading update drove a 7.8% jump, extending to nearly 11% over five sessions. The June 10 result was the outlier: the stock fell 13.6% that day and held most of those losses through the week. With the next print due October 30, the question is whether the past month's selling reflects positioning ahead of a potentially weak number, or whether it has already priced in a disappointing outcome.
What to watch heading into October 30 is whether the borrow cost continues its rise in the absence of actual short interest buildup, and how the stock reacts in the days immediately after the print given the wide gap between the stale analyst consensus and the current price.
Stocks in this article
See the live data behind this article on ORTEX.
Open 2589 on ORTEX →How this article was generated
- Generated
- 20 Oct 2026, 17:31
- Data as of
- 20 Oct 2026, 17:31
- Prompt version
- v1.0
- Data sources
- Short interestUtilizationEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.